FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4074401000001100: Report all adverse reactions to the CSM (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
10072501000001113 Report all adverse reactions to the CSM en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36829301000001115 Report all adverse reactions to the CSM (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Report all adverse reactions to the CSM Is a CSM warning status messages true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dolasetron mesilate 50mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Dolasetron mesilate 20mg/mL injection solution 5mL vial CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Anzemet 20mg/mL injection solution 5mL vial CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Anzemet 200mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
OxyNorm 10mg/mL injection solution 1mL ampoule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Oxycodone hydrochloride 10mg/mL injection solution 2mL ampoule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Oxycodone hydrochloride 10mg/mL injection solution 1mL ampoule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Frovatriptan 2.5mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Hepsera 10mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Enfuvirtide 90mg/mL injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ethinylestradiol+norelgestromin 600micrograms/6mg transdermal patch CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Methyl aminolevulinate 160mg/g cream CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rapamune 2mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sirolimus 2mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Pegfilgrastim 6mg/0.6mL injection solution prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Neulasta 6mg/0.6mL injection solution prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Zavesca 100mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Carbaglu 200mg dispersible tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Valdecoxib 20mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Valdecoxib 40mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Bextra 10mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
InductOs 12mg kit CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Iomeprol 200mg(I)/mL injection solution CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Olmesartan medoxomil 20mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Dolasetron mesilate 200mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Anzemet 20mg/mL injection solution 0.625mL vial CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
OxyNorm 10mg/mL injection solution 2mL ampoule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Migard 2.5mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Adalimumab 40mg injection solution 0.8mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Miglustat 100mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Valdecoxib 10mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Bextra 20mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sulphur hexafluoride 40microlitres injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Olmetec 10mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Dolasetron mesilate 20mg/mL injection solution 0.625mL vial CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Anzemet 50mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Adefovir dipivoxil 10mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Evra transdermal patch CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Humira 40mg injection solution 0.8mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Carglutamic acid 200mg dispersible tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Bextra 40mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Olmetec 40mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Forsteo 250micrograms/mL injection solution 3mL prefilled pen CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ezetrol 10mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Teriparatide 250micrograms/mL injection solution 3mL prefilled pen CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Dibotermin alfa 12mg kit CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Metvix 160mg/g cream CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Fuzeon 90mg/mL injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier

Start Previous Page 8 of 8

This concept is not in any reference sets

Back to Start